Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Copper Histidinate data to be presented at 2022 American College of Medical Genetics Annual Clinical…
The previously reported results are from an efficacy and safety analysis of data integrated from two completed pivotal studies in…
Lonza signs manufacturing agreement with Oasmia for ovarian cancer drug
Under the agreement, Lonza will provide kilogram-scale synthesis, purification and stability testing of Cantrixil, and deliver…
Alembic Pharma receives US FDA final approval for Lacosamide tablets
Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
AstraZeneca COVID drug neutralises Omicron sub-variants in lab study
This is the first data looking at the impact of AstraZeneca's Evusheld treatment on "cousins" of the Omicron variant following a…
Hetero receives CDSCO approval to manufacture Sputnik Light vaccine for sale in India
Hetero is the first biopharma company in India to receive Manufacturing and Marketing (M&M) approval for the product…
Glenmark Pharma receives ANDA approval for Lacosamide tablets
The company plans to launch the product immediately
Second Covishield dose can be given between eight to16 weeks after first dose: NTAGI
Currently, the second dose of Covishield is given between 12-16 weeks after the first dose under the National COVID-19 Vaccination…
US FDA approves new Bristol Myers cancer immunotherapy
The company said it expects the treatment to eventually garner annual sales of more than $4 billion
US FDA approves Marinus Pharma’s lead drug to treat genetic disorder
The oral drug, which will be sold under the brand name Ztalmy, is intended specifically for treatment of seizures associated with…
Biolexis to collaborate with Akston Biosciences for COVID-19 vaccine
In a joint statement, the two companies said they will collaborate for the production and sales of Akston's AKS-452, a protein…